Hotchkiss, K., Brown, M. C., Threatt, S., Low, J. T., Anand, M., Goldston, M., … Khasraw, M. (2025). Abstract CT056: A phase 1 study of intratumoral HSV1 co-expressing IL-12 and PD1 blocking antibody (MVR-C5252) in recurrent high-grade glioma. In Cancer Research (Vol. 85, pp. CT056–CT056). American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7445.am2025-ct056

Hotchkiss, Kelly, Michael C. Brown, Stevie Threatt, Justin T. Low, Monika Anand, Melody Goldston, Claire Bradbury, et al. “Abstract CT056: A phase 1 study of intratumoral HSV1 co-expressing IL-12 and PD1 blocking antibody (MVR-C5252) in recurrent high-grade glioma.” In Cancer Research, 85:CT056–CT056. American Association for Cancer Research (AACR), 2025. https://doi.org/10.1158/1538-7445.am2025-ct056.

Hotchkiss K, Brown MC, Threatt S, Low JT, Anand M, Goldston M, et al. Abstract CT056: A phase 1 study of intratumoral HSV1 co-expressing IL-12 and PD1 blocking antibody (MVR-C5252) in recurrent high-grade glioma. In: Cancer Research. American Association for Cancer Research (AACR); 2025. p. CT056–CT056.

Hotchkiss, Kelly, et al. “Abstract CT056: A phase 1 study of intratumoral HSV1 co-expressing IL-12 and PD1 blocking antibody (MVR-C5252) in recurrent high-grade glioma.” Cancer Research, vol. 85, no. 8_Supplement_2, American Association for Cancer Research (AACR), 2025, pp. CT056–CT056. Crossref, doi:10.1158/1538-7445.am2025-ct056.

Hotchkiss K, Brown MC, Threatt S, Low JT, Anand M, Goldston M, Bradbury C, Dean K, Herndon JE, Patel AP, Grant GA, Ashley DM, Desjardins A, Khasraw M. Abstract CT056: A phase 1 study of intratumoral HSV1 co-expressing IL-12 and PD1 blocking antibody (MVR-C5252) in recurrent high-grade glioma. Cancer Research. American Association for Cancer Research (AACR); 2025. p. CT056–CT056.